参考文献/References:
[1] ANGUS D C, van der POLL T. Severe sepsis and septic shock[J]. The New England journal of medicine, 2013, 369(9):840-851.
[2] BAUER M, GERLACH H, VOGELMANN T, et al. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis[J]. Critical Care(London, England), 2020, 24(1):239.
[3] HENSLEY M K, DONNELLY J P, CARLTON E F, et al. Epidemiology and outcomes of cancer-related versus non-cancer-related sepsis hospitalizations[J]. Critical Care Medicine, 2019, 47(10):1310-1316.
[4] NELMES E, EDWARDS L, JHANJI S, et al. Patients with cancer and sepsis trials: an unfair representation?[J]. Clinical Medicine(London, England), 2023, 23(6):635-636.
[5] SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for sepsis and septic shock(Sepsis-3)[J]. Jama, 2016, 315(8):801-810.
[6] RANIERI V M, RUBENFELD G D, THOMPSON B T, et al. Acute respiratory distress syndrome: the Berlin Definition[J]. Jama, 2012, 307(23):2526-2533.
[7] QIU X, LEI Y P, ZHOU R X. SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis[J]. Expert Review of Anti-infective Therapy, 2023, 21(8):891-900.
[8] de GROOTH H J, GEENEN I L, GIRBES A R, et al. SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis[J]. Critical Care(London, England), 2017, 21(1):38.
[9] 张洁, 佘丹阳, 冯丹, 等. SOFA评分及其动态变化比APACHEⅡ评分能更好反映脓毒症病情严重程度及预后[C]. 广州:中华医学会第五次全国重症医学大会, 2021.
[10] KOCHANEK M, SCHALK E, von BERGWELT-BAILDPN M, et al. Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party(AGIHO)and Intensive Care Working Party(iCHOP)of the German Society of Hematology and Medical Oncology(DGHO)[J]. Annals of Hematology, 2019, 98(5):1051-1069.
[11] DANAI P A, MOSS M, MANNINO D M, et al. The epidemiology of sepsis in patients with malignancy[J]. Chest, 2006, 129(6):1432-1440.
[12] WANG Y G, ZHOU J C, WU K S. High 28-day mortality in critically ill patients with sepsis and concomitant active cancer[J]. The Journal of International Medical Research, 2018, 46(12):5030-5039.
[13] LIU Y C, YAO Y, YU M M, et al. Frequency and mortality of sepsis and septic shock in China: a systematic review and meta-analysis[J]. BMC Infectious Diseases, 2022, 22(1):564.
相似文献/References:
[1]林兴盛,石松长.肝素治疗对严重脓毒症患者肺、肾功能的影响[J].福建医药杂志,2017,39(4):108.
[2]林树春 胡晓华 赖海春 林 勤.头颈部鳞状细胞癌患者体内免疫抑制性细胞因子与调节性T细胞的表达分析[J].福建医药杂志,2020,42(03):23.
LIN Shuchun,HU Xiaohua,LAI Haichun,et al.Analysis of expression of immunosuppressive cytokines and regulatory T cells in patients with head and neck squamous cell carcinoma[J].FUJIAN MEDICAL JOURNAL,2020,42(05):23.
[3]叶 彦,任 飞 综述 黄慧恒 审校.血清NTx和ICTP在恶性肿瘤骨转移中的临床意义[J].福建医药杂志,2021,43(02):153.
[4]林爱芳,甘巧蓉,吴旭玮.血清程序性死亡蛋白1和高迁移率族蛋白1水平与脓毒症并发肝损伤的相关性研究[J].福建医药杂志,2024,46(01):8.[doi:10.20148/j.fmj.2024.01.003]
LIN Aifang,GAN Qiaorong,WU Xuwei.Study on correlation of serum PD1 and HMGB1 with liver injury in patients with sepsis[J].FUJIAN MEDICAL JOURNAL,2024,46(05):8.[doi:10.20148/j.fmj.2024.01.003]
[5]刘加夫,张宏英,陈晓红,等.荧光ROSE在肺恶性肿瘤细胞学诊断中的应用分析[J].福建医药杂志,2024,46(04):6.[doi:10.20148/j.fmj.2024.04.002]
LIU Jiafu,ZHANG Hongying,CHEN Xiaohong,et al.Analysis of fluorescence ROSE in cytological diagnosis of lung malignant tumors[J].FUJIAN MEDICAL JOURNAL,2024,46(05):6.[doi:10.20148/j.fmj.2024.04.002]
[6]陈伟,李燚,赖橼.脓毒症心肌抑制大鼠PTEN-PI3K-Akt信号通路的激活对心肌组织损伤及凋亡的影响[J].福建医药杂志,2024,46(07):72.[doi:10.20148/j.fmj.2024.07.023]